Apr 29, 2022 This Week in Cardiology Podcast
This Week in Cardiology
Medscape Podcasts
4.9 • 963 Ratings
🗓️ 29 April 2022
⏱️ 22 minutes
🧾️ Download transcript
Summary
Aspirin for primary prevention, time-restricted feeding, renal denervation, and a potential new obesity drug are the topics John Mandrola, MD, covers in this week's podcast.
This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic
I – ASA for Primary Prevention:
- USPSTF Final Recommendation on Aspirin for Primary CV Prevention https://www.medscape.com/viewarticle/972761
- Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement https://jamanetwork.com/journals/jama/fullarticle/2791399
- Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly https://www.nejm.org/doi/10.1056/NEJMoa1805819
- Effect of Aspirin on All-Cause Mortality in the Healthy Elderly https://www.nejm.org/doi/full/10.1056/NEJMoa1803955
II – Time Restricted Feeding
- Is There a Benefit to Fasting Plus Calorie Counting? https://www.medscape.com/viewarticle/972579
- Calorie Restriction with or without Time-Restricted Eating in Weight Loss https://www.nejm.org/doi/full/10.1056/NEJMoa2114833
- Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity. The TREAT Randomized Clinical Trial https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2771095
III – Renal Denervation
- Renal Denervation BP Benefits Remain at 3 Years: SPYRAL HTN-ON https://www.medscape.com/viewarticle/971883
- Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial https://doi.org/10.1016/S0140-6736(22)00455-X
IV – Tirzepatide for Obesity
- Tirzepatide Excites in Obesity Now Too, Says Lilly https://www.medscape.com/viewarticle/972936
- Lilly's tirzepatide delivered up to 22.5% weight loss in adults with obesity or overweight in SURMOUNT-1 https://www.prnewswire.com/news-releases/lillys-tirzepatide-delivered-up-to-22-5-weight-loss-in-adults-with-obesity-or-overweight-in-surmount-1--301534871.html
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net
Transcript
Click on a timestamp to play from that location
| 0:00.0 | You're listening to this week in cardiology from the heart |
| 0:03.4 | org medscape cardiology this podcast is intended for health care |
| 0:07.6 | professionals only any views expressed are the presenters own and do not |
| 0:11.2 | necessarily reflect the views of WebMD or Medscape. |
| 0:15.1 | You can now access the latest in medical news on your Amazon Alexa-enabled device. |
| 0:19.7 | Join me, Perry Wilson, every weekday morning for Medscape Medical Minute where I |
| 0:23.7 | highlight the top medical stories of the day. To add Medscape Medical |
| 0:27.4 | Minute to your flash briefing search for Medscape Medical Minute on Amazon |
| 0:31.1 | and click enable or open the Amazon Alexa app go to skills search for |
| 0:35.6 | Medscape Medical Minute and click enable then say Alexa what's the news or |
| 0:40.8 | Alexa what's my flash briefing I hope you'll join us. |
| 0:44.0 | Hi everyone this is John Mandrola from the heart |
| 0:47.4 | or medscape cardiology and this is this week in cardiology for April 29th, 2022. |
| 0:55.0 | This week, aspirin, time-restricted feeding, |
| 0:59.5 | renal denervation, and a possible new breakthrough in obesity management. |
| 1:05.0 | First topic today is aspirin. |
| 1:09.0 | This week, the United States Preventative Services Task Force, the US, PS, TF, updated their recommendation |
| 1:16.0 | on the use of LODOS aspirin for primary prevention. |
| 1:20.0 | Before I tell you though about the aspirin decision decision here are three points of clarification on that first leading sentence. |
| 1:26.5 | First, the USPSTF is one of my favorite guideline committees. |
| 1:32.0 | They are independent experts trained in evaluation of evidence. |
| 1:36.1 | There is close to neutral Martian evaluators of evidence that we get. They are the opposite of |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.